IL183554A - Oral immediate release formulation of a poorly water-soluble active substance - Google Patents

Oral immediate release formulation of a poorly water-soluble active substance

Info

Publication number
IL183554A
IL183554A IL183554A IL18355407A IL183554A IL 183554 A IL183554 A IL 183554A IL 183554 A IL183554 A IL 183554A IL 18355407 A IL18355407 A IL 18355407A IL 183554 A IL183554 A IL 183554A
Authority
IL
Israel
Prior art keywords
active substance
immediate release
release formulation
poorly water
soluble active
Prior art date
Application number
IL183554A
Other languages
English (en)
Other versions
IL183554A0 (en
Original Assignee
Solvay Pharm Bv
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/056970 external-priority patent/WO2006067150A1/en
Application filed by Solvay Pharm Bv, Panacea Biotec Ltd filed Critical Solvay Pharm Bv
Publication of IL183554A0 publication Critical patent/IL183554A0/en
Publication of IL183554A publication Critical patent/IL183554A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL183554A 2004-12-23 2007-05-30 Oral immediate release formulation of a poorly water-soluble active substance IL183554A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63811104P 2004-12-23 2004-12-23
EP04106933 2004-12-23
PCT/EP2005/056970 WO2006067150A1 (en) 2004-12-23 2005-12-20 Oral immediate release formulation of a poorly watersoluble active substance

Publications (2)

Publication Number Publication Date
IL183554A0 IL183554A0 (en) 2007-09-20
IL183554A true IL183554A (en) 2011-07-31

Family

ID=35890662

Family Applications (1)

Application Number Title Priority Date Filing Date
IL183554A IL183554A (en) 2004-12-23 2007-05-30 Oral immediate release formulation of a poorly water-soluble active substance

Country Status (4)

Country Link
KR (1) KR20070104890A (de)
DE (1) DE602005019919D1 (de)
IL (1) IL183554A (de)
NO (1) NO20073728L (de)

Also Published As

Publication number Publication date
IL183554A0 (en) 2007-09-20
DE602005019919D1 (de) 2010-04-22
NO20073728L (no) 2007-07-18
KR20070104890A (ko) 2007-10-29

Similar Documents

Publication Publication Date Title
HK1077218A1 (en) Oral solid solution formulation of a poorly water-soluble active substance
IL177120A0 (en) Formulations for poorly soluble drugs
IL179992A0 (en) Immediate release formulations of memantine oral dosage forms
HK1129590A1 (en) Multiple unit type sustained release oral formulation and process for the preparation thereof
ZA200705530B (en) Sustained release pharmaceutical formulations
IL181680A0 (en) Tablets with site time -controlled gastrointestinal release of active ingredient
ZA200703571B (en) Gabapentin prodrug sustained release oral dosage forms
IL180031A0 (en) Stable pharmaceutical formulations of benzimidazole compounds
EP1895991A4 (de) Formulierungen mit modifizierter freisetzung von arzneimitteln gegen erregbarkeit
ZA200804427B (en) Nanoparticulate active ingredient formulations
TWI319317B (en) Modified release pharmaceutical formulation
IL178475A0 (en) Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof
FR2904219B1 (fr) Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant
EP1753405A4 (de) Pharmazeutische formulierung mit kontrollierter freisetzung
HK1113308A1 (en) Pharmaceutical formulations of gallium salts
EP1750680A4 (de) Druckbeschichtete formulierungen mit kontrollierter freisetzung aus wasserlöslichen wirkstoffen
EP1755568A4 (de) Formulierung mit kontrollierter freisetzung zur oralen verabreichung von metformin
IL165069A0 (en) Immediate release pharmaceutical formulation
PL1848439T3 (pl) Doustna formulacja o natychmiastowym uwalnianiu słabo rozpuszczalnej w wodzie substancji aktywnej
IL183554A (en) Oral immediate release formulation of a poorly water-soluble active substance
ZA200705021B (en) Oral immediate release formulation of a poorly water-soluble active substance
HK1122731A1 (en) Prolonged release formulation of active pharmaceutical ingredients
ZA200705080B (en) Aminocarboxylic acid derivative and medicinal use thereof
ZA200810478B (en) Oral pharmaceutical composition of a poorly water-soluble active substance
ZA200810240B (en) Oral pharmaceutical composition of a poorly water-soluble active substance

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees